![](/img/cover-not-exists.png)
WS7.5 Interim results of the phase 3 open-label study of ataluren in nonsense mutation cystic fibrosis (nmCF)
Kerem, E., Wilschanski, M., Sermet-Gaudelus, I., De Boeck, K., Accurso, F.J., Konstan, M., Rowe, S., Miller, N., Elfring, G., Spiegel, R., Peltz, S., Barth, J., Ajayi, T.Volume:
12
Language:
english
Journal:
Journal of Cystic Fibrosis
DOI:
10.1016/S1569-1993(13)60044-2
Date:
June, 2013
File:
PDF, 61 KB
english, 2013